학술논문

EP14.05-004 Temozolomide and Atezolizumab as Second Line Treatment for Extensive Stage Small Cell Lung Cancer: A Randomized, Multi-Cohort Phase 2 Trial
Document Type
Abstract
Source
In Journal of Thoracic Oncology September 2022 17(9) Supplement:S544-S545
Subject
Language
ISSN
1556-0864